Chang R.S.L., Lotti V.J. Biochemical and pharmacological characterization of a new extremely potent and selective non peptide cholecystokinin antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;4923-4926.
Cherner J.A., Sutliff V.E., Grybowski D.M., Jensen R.T., Gardner J.D. Functionally distinct receptors for cholecystokinin and gastrin on dispersed chief cells from guinea pig stomach. Am. J. Physiol. 254:1988;G151-155.
Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides. 15:1994;731-755.
Delarge J., Lapiere C.L. Synthèseet propriétés pharmacologiques de quelques N-acylsulfonamides. Ann. Pharm. Fr. 32:1974;657-667.
de Tullio P., Pirotte B., Dupont L., Masereel B., Laeckmann D., Podona T., Diouf O., Lebrun P., Delarge J. Synthesis and structural studies of a new class of heterocyclic compounds: 1,2,4-pyridothiadiazine 1,1-dioxides, pyridyl analogues of 1,2,4-benzothiadiazine 1,1-dioxides. Tetrahedron. 51:1995;3221-3234.
Dourish C.T., Hill D.R. Trends Pharmacol. Sci. 8:1987;207-208.
Evans B.E., Bock M.G., Rittle K.E., DiPardo R.M., Whitter W.L., Veber D.F., Anderson P.S., Freidinger R.M. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc. Natl. Acad. Sci. USA. 83:1986;4918-4922.
Evans B.E., Rittle K.E., Bock M.G., DiPardo R.M., Freidinger R.M., Whitter W.L., Gould N.P., Lundell G.F., Homnick C.F., Veber D.F., Anderson P.S., Chang R.S.L., Lotti V.J., Cerino D.J., Chen T.B., Kling P.J., Kunkel K.A., Springer J.P., Hisshfield J. Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists. J. Med. Chem. 30:1987;1229-1239.
Farlow D.S., Flaugh M.E., Horvath S.D., Lavagnino E.D., Pranc P. Two efficient syntheses of indole-3-propionic esters and acids. Further applications of the meldrum's acid. Org. Prep. Proc. Inc. 13:1981;39-48.
Goëtz M.A., Lopez M., Monaghan R.L., Chang R.S.L., Lotti V.J., Chen T.B. Asperlicin, a novel non-peptidal cholecystokinin antagonist from aspergillus alliaceus: fermentation, isolation and biological properties. J. Antibiot. 41:1985;875-877.
Makovec F., Chisté R., Bani M., Revel L., Setnikar I., Rovati L.A. New glutamic and aspartic derivatives with potent CCK-antagonistic activity. Eur. J. Med. Chem. Chim. Ther. 21:1986;9-20.
Moran T.H., Robinson P.H., Goldrich M.S., McHugh P.R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 362:1986;175-179.
Mutt V., Jorpes E. Hormonal polypeptides in the upper intestine. Biochem. J. 125:1971;57P-58P.
Pirotte B., de Tullio P., Lebrun P., Antoine M.H., Fontaine J., Masereel B., Schynts M., Dupont L., Herchuelz A., Delarge J. 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers? J. Med. Chem. 36:1993;3211-3213.
Van Dijk A., Richards J.G., Trzeciak A., Gillessen D., Mohler H. Cholecystokinin receptors: biochemical demonstration and autoradiographied localization in rat brain and pancreas using [3H]-cholecystokini-8 as radioligand. J. Neurosci. 4:1984;1021-1033.
